Skip to content

Facilitating the Implementation of Population-wide Genomic Screening

Facilitating the Implementation of Population-wide Genomic Screening

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07806643
Acronym
FOCUS
Enrollment
8
Registered
2026-09-08
Start date
2027-01-01
Completion date
2028-10-01
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Population Genomic Screening Implementation Best Practices

Brief summary

This is a multi-site hybrid implementation-effectiveness trial that uses a stepped-wedge cluster randomized design to evaluate the impact of the FOCUS toolkit, a multicomponent implementation guide, on improving the implementation of population-wide genomic screening (PGS) programs across diverse healthcare settings. The trial will assess program-level outcomes using the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance) and explore mechanisms of change and implementation process progression. The study involves program-level and individual-level data collection and will not alter clinical care or treatment decisions of individuals made by participating sites.

Detailed description

To help facilitate growth of population-wide genomic screening (PGS) programs and enhance recruitment and retention of representative populations into genomic initiatives, this study propose to identify best practices for PGS implementation and develop and test a freely available, online multicomponent implementation guide (FOCUS toolkit). This project will establish a gold standard approach for integrating PGS and offer the field generalizable methods and knowledge about PGS implementation. Specifically, using a stakeholder-engaged Implementation Mapping approach we will: 1) conduct a qualitative needs assessment among ten PGS programs (FOCUS design sites) at various implementation stages (emerging, implementing, sustaining) guided by the Consolidated Framework for Implementation Research, 2) develop and produce the FOCUS toolkit consisting of implementation strategies, materials, and protocols, and 3) evaluate the impact of the FOCUS toolkit on Reach, Effectiveness, Implementation, Adoption, Maintenance outcomes for PGS in 12 PGS sites (FOCUS test sites) using a stepped wedge cluster randomized trial design. These findings will: 1) provide a standardized approach and evaluation framework for programs seeking to strategically implement and expand population-based approaches for identifying individuals and families at high risk of serious, yet preventable disease, 2) provide generalizable methods and knowledge about PGS, and 3) support efforts to bring the promise of precision health to all.

Interventions

OTHERFOCUS Toolkit Training

The FOCUS toolkit is a multicomponent implementation guide on improving the implementation of population-wide genomic screening programs across diverse healthcare settings.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER
National Human Genome Research Institute (NHGRI)
CollaboratorNIH

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Operate an active or population genomic screening (PGS) program. * Agree to utilize the FOCUS Toolkit throughout the trial and engage staff in its use and fidelity tracking. * Ability to understand and willingness to sign a data use agreement and comply with study procedures for the entire length of the study. * Ability to provide program-level data (Reach, Effectiveness, Adoption, Implementation, Maintenance) quarterly. * Confirmation of implementing or sustaining stage, as determined by the investigator. * Capacity to participate in stakeholder surveys and interviews at study conclusion. * Ability to read and understand the English language.

Exclusion criteria

* They lack infrastructure to collect and share required data. * They cannot commit to toolkit use or quarterly reporting. * They are unable to comply with study timelines

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of Intervention Measure (AIM)Month 19Implementation will be assessed using the Acceptability of Intervention Measure survey includes 4 items with the total score range 4-20. Higher scores indicate higher level of acceptability.
Intervention Appropriateness Measure (IAM)Month 19Implementation will be assessed using the Intervention Appropriateness Measure survey includes 4 items with a total score range 4-20. Higher scores indicate higher level of appropriateness.
Feasibility of Intervention Measure (FIM)Month 19Implementation will be assessed using the Feasibility of Intervention Measure survey includes 4 items with a total score range 4-20. Higher scores indicate higher level of feasibility.
Number of Individuals that Completed High-Risk ManagementMonth 19Maintenance will be assessed by the number of individuals with positive results that completed high-risk management
Program Sustainability AssessmentMonth 19Maintenance will be assessed by using the Program Sustainability Assessment survey has 40 items with a total score range of 40-280. Higher scores indicate greater sustainability capacity.
Number of People Participating in PGS ProgramMonth 4Reach is measured as the total number of people who have consented to participate in the population-based genomic screening (PGS) program. Data will be collected from PGS program data collection form
Proportion of Eligible Individuals TestedMonth 4Effectiveness is measured as the proportion of eligible individuals tested compared to those consented
Proportion of Positive Genomic Screening ResultsMonth 4Number of individuals with positive results after genomic screening
Proportion of Negative Genomic Screening ResultsMonth 4Number of individuals with negative results after genomic screening
Proportion of VUS Genomic Screening ResultsMonth 4Number of individuals with variant of uncertain significance (VUS) after genomic screening
Number of Sites Participating in PGSMonth 19Adoption is defined as the uptake of population-based genomic screening (PGS) at each site, measured by the number of sites participating in PGS relative to those eligible. Measured through stakeholder surveys

Countries

United States

Contacts

CONTACTCaitlin Allen, PhD
Caitlin.Allen@wfusm.edu614-554-5298
PRINCIPAL_INVESTIGATORCaitlin Allen, PhD

Atrium Health Wake Forest Baptist

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026